3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD

The 3TR (Taxonomy, Treatments, Targets and Remission) consortium is the largest IMI (Innovative Medicine Initiative) project ever started in the field of immune diseases (https://3tr-imi.eu/). 3TR is unique in bringing several medical specialties, encompassing respiratory medicine, rheumatology, neurology and gastroenterology, together, to study disease mechanisms across seven disease entities: asthma, COPD, systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, ulcerative colitis and Crohn's disease.

Source: European Respiratory Journal - October 21, 2021 Category: Respiratory Medicine Authors: Porsbjerg, C., Maitland-van der Zee, A. H., Brusselle, G., Canonica, G. W., Agusti, A., Faner, R., Vogelmeier, C. F., Nawijn, M., van den Berge, M., Rusconi, F., Pilette, C., Ramiconi, V., Coleman, C., Chaudhuri, R., Chung, K. F., Wedzicha, J., Saglani, S Tags: Editorials Source Type: research